116 related articles for article (PubMed ID: 30759394)
1. Release of Immunomodulatory Ebola Virus Glycoprotein-Containing Microvesicles Is Suppressed by Tetherin in a Species-Specific Manner.
Nehls J; Businger R; Hoffmann M; Brinkmann C; Fehrenbacher B; Schaller M; Maurer B; Schönfeld C; Kramer D; Hailfinger S; Pöhlmann S; Schindler M
Cell Rep; 2019 Feb; 26(7):1841-1853.e6. PubMed ID: 30759394
[TBL] [Abstract][Full Text] [Related]
2. Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat Cells.
Hoffmann M; Nehlmeier I; Brinkmann C; Krähling V; Behner L; Moldenhauer AS; Krüger N; Nehls J; Schindler M; Hoenen T; Maisner A; Becker S; Pöhlmann S
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429347
[TBL] [Abstract][Full Text] [Related]
3. The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies.
Brinkmann C; Nehlmeier I; Walendy-Gnirß K; Nehls J; González Hernández M; Hoffmann M; Qiu X; Takada A; Schindler M; Pöhlmann S
J Virol; 2016 Dec; 90(24):11075-11086. PubMed ID: 27707924
[TBL] [Abstract][Full Text] [Related]
4. A GXXXA Motif in the Transmembrane Domain of the Ebola Virus Glycoprotein Is Required for Tetherin Antagonism.
González-Hernández M; Hoffmann M; Brinkmann C; Nehls J; Winkler M; Schindler M; Pöhlmann S
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669839
[TBL] [Abstract][Full Text] [Related]
5. Ebola Virus Glycoprotein Promotes Enhanced Viral Egress by Preventing Ebola VP40 From Associating With the Host Restriction Factor BST2/Tetherin.
Gustin JK; Bai Y; Moses AV; Douglas JL
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S181-90. PubMed ID: 25821226
[TBL] [Abstract][Full Text] [Related]
6. The Ebola virus glycoprotein and HIV-1 Vpu employ different strategies to counteract the antiviral factor tetherin.
Kühl A; Banning C; Marzi A; Votteler J; Steffen I; Bertram S; Glowacka I; Konrad A; Stürzl M; Guo JT; Schubert U; Feldmann H; Behrens G; Schindler M; Pöhlmann S
J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S850-60. PubMed ID: 21987761
[TBL] [Abstract][Full Text] [Related]
7. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
[No Abstract] [Full Text] [Related]
8. Ebolaviruses Associated with Differential Pathogenicity Induce Distinct Host Responses in Human Macrophages.
Olejnik J; Forero A; Deflubé LR; Hume AJ; Manhart WA; Nishida A; Marzi A; Katze MG; Ebihara H; Rasmussen AL; Mühlberger E
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331091
[TBL] [Abstract][Full Text] [Related]
9. Ebolavirus Replication and Tetherin/BST-2.
Yasuda J
Front Microbiol; 2012; 3():111. PubMed ID: 22485110
[TBL] [Abstract][Full Text] [Related]
10. Specific neutralizing response in plasma from convalescent patients of Ebola Virus Disease against the West Africa Makona variant of Ebola virus.
Luczkowiak J; Arribas JR; Gómez S; Jiménez-Yuste V; de la Calle F; Viejo A; Delgado R
Virus Res; 2016 Feb; 213():224-229. PubMed ID: 26739425
[TBL] [Abstract][Full Text] [Related]
11. Requirements within the Ebola Viral Glycoprotein for Tetherin Antagonism.
Vande Burgt NH; Kaletsky RL; Bates P
Viruses; 2015 Oct; 7(10):5587-602. PubMed ID: 26516900
[TBL] [Abstract][Full Text] [Related]
12. Blocking of ebolavirus spread through intercellular connections by an MPER-specific antibody depends on BST2/tetherin.
Santos RI; Ilinykh PA; Pietzsch CA; Ronk AJ; Huang K; Kuzmina NA; Zhou F; Crowe JE; Bukreyev A
Cell Rep; 2023 Oct; 42(10):113254. PubMed ID: 37858466
[TBL] [Abstract][Full Text] [Related]
13. Is tetherin a true antiviral: The influenza a virus controversy.
Sharma A; Lal SK
Rev Med Virol; 2019 May; 29(3):e2036. PubMed ID: 30706579
[TBL] [Abstract][Full Text] [Related]
14. Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.
Schweneker M; Laimbacher AS; Zimmer G; Wagner S; Schraner EM; Wolferstätter M; Klingenberg M; Dirmeier U; Steigerwald R; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331098
[TBL] [Abstract][Full Text] [Related]
15. Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine.
Kimble JB; Malherbe DC; Meyer M; Gunn BM; Karim MM; Ilinykh PA; Iampietro M; Mohamed KS; Negi S; Gilchuk P; Huang K; Wolf YI; Braun W; Crowe JE; Alter G; Bukreyev A
J Virol; 2019 Feb; 93(4):. PubMed ID: 30518655
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of Ebola virus glycoprotein interactions with human and bat cells.
Kühl A; Hoffmann M; Müller MA; Munster VJ; Gnirss K; Kiene M; Tsegaye TS; Behrens G; Herrler G; Feldmann H; Drosten C; Pöhlmann S
J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S840-9. PubMed ID: 21987760
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of propagation-restricted vesicular stomatitis virus encoding Ebola virus glycoprotein in guinea pigs.
Locher S; Schweneker M; Hausmann J; Zimmer G
J Gen Virol; 2018 Jul; 99(7):866-879. PubMed ID: 29869979
[TBL] [Abstract][Full Text] [Related]
18. Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.
Kaletsky RL; Francica JR; Agrawal-Gamse C; Bates P
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2886-91. PubMed ID: 19179289
[TBL] [Abstract][Full Text] [Related]
19. Development and Characterization of Neutralizing Antibodies Against Zaire Ebolavirus Glycoprotein and Protein 40.
Yu DS; Weng TH; Shen L; Wu XX; Hu CY; Wang FXC; Wu ZG; Wu HB; Wu NP; Li LJ; Yao H
Cell Physiol Biochem; 2018; 50(3):1055-1067. PubMed ID: 30355918
[TBL] [Abstract][Full Text] [Related]
20. Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice.
Bengtsson KL; Song H; Stertman L; Liu Y; Flyer DC; Massare MJ; Xu RH; Zhou B; Lu H; Kwilas SA; Hahn TJ; Kpamegan E; Hooper J; Carrion R; Glenn G; Smith G
Vaccine; 2016 Apr; 34(16):1927-35. PubMed ID: 26921779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
